TNXP
Tonix Pharmaceuticals Holding Corp.
Company overview
- Market capitalization
- $169.80M
- Employees
- 142
- Latest publication
- 2026-09-29
About Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase for the treatment of cocaine intoxication; TNX-1500, an Fc-modified humanized monoclonal antibody to prevent kidney transplant rejection, as well as to treat autoimmune conditions; TNX-4800, a humanized monoclonal antibody for the seasonal prevention of Lyme disease; and TNX-2900, an intranasal oxytocin potentiated with magnesium for the treatment of Prader-Willi syndrome. Further, it is developing TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, and arginine-vasopressin deficiency; TNX-801, a live horsepox vaccine for the prevention of smallpox and mpox; TNX-4200, a small molecule broad-spectrum antiviral agent targeting CD45 for the treatment or prevention of viral disease; TNX-4900, a highly selective small-molecule Sigma-1 receptor antagonist for neuropathic pain; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; and TNX-1800 and TNX-1850, live modified horsepox vaccines for the prevention of COVID. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,878,000USD | 5,390,000USD | 3,290,000USD | 1,998,000USD | 2,429,000USD | 2,582,000USD | 2,822,000USD | 2,208,000USD |
| Cost Of Revenue | 2,133,000USD | 1,546,000USD | 1,367,000USD | 3,272,000USD | 943,000USD | 1,183,000USD | 1,555,000USD | 3,367,000USD |
| Gross Profit | 4,745,000USD | 3,844,000USD | 1,923,000USD | -1,274,000USD | 1,486,000USD | 1,399,000USD | 1,267,000USD | -1,159,000USD |
| Research Development | 18,213,000USD | 16,941,000USD | 9,289,000USD | 10,820,000USD | 7,436,000USD | 8,297,000USD | 9,114,000USD | 9,698,000USD |
| Selling General Administrative | 28,624,000USD | 26,306,000USD | 25,701,000USD | 16,202,000USD | 10,104,000USD | 3,400,000USD | 7,707,000USD | 7,502,000USD |
| Total Operating Expenses | 46,282,000USD | 52,130,000USD | 34,990,000USD | 27,022,000USD | 17,540,000USD | 23,879,000USD | 16,821,000USD | 17,200,000USD |
| Operating Income | -41,537,000USD | -48,286,000USD | -33,067,000USD | -28,296,000USD | -16,054,000USD | -22,480,000USD | -15,554,000USD | -18,359,000USD |
| Interest Income | 1,346,000USD | 1,344,000USD | 1,231,000USD | 943,000USD | 394,000USD | — | 18,000USD | 1,000USD |
| Net Interest Income | 1,346,000USD | 1,344,000USD | 1,231,000USD | 943,000USD | 394,000USD | — | -283,000USD | 1,000USD |
| Income Before Tax | -40,194,000USD | -46,910,000USD | -32,009,999USD | -28,272,000USD | -16,829,000USD | -22,108,000USD | -14,213,000USD | -78,776,000USD |
| Net Income | -40,194,000USD | -46,910,000USD | -32,009,999USD | -28,272,000USD | -16,829,000USD | -22,108,000USD | -14,213,000USD | -78,776,000USD |
| Net Income From Continuing Ops | -40,194,000USD | -46,910,000USD | -32,010,000USD | -28,272,000USD | -16,829,000USD | -22,108,000USD | -14,213,000USD | -78,776,000USD |
| Ebit | -41,537,000USD | -48,286,000USD | -32,009,999USD | -28,296,000USD | -16,829,000USD | -22,108,000USD | -15,554,000USD | -18,359,000USD |
| Ebitda | -40,982,000USD | -47,798,000USD | -31,548,999USD | -27,813,000USD | -16,336,000USD | -21,612,000USD | -15,044,000USD | -17,154,000USD |
| Depreciation And Amortization | 555,000USD | 488,000USD | 461,000USD | 483,000USD | 493,000USD | 496,000USD | 510,000USD | 1,205,000USD |
| Reconciled Depreciation | 555,000USD | 488,000USD | 461,000USD | 483,000USD | 493,000USD | 496,000USD | 510,000USD | 1,205,000USD |
| Total Other Income Expense Net | 1,343,000USD | 1,376,000USD | 1,057,000USD | 24,000USD | -775,000USD | 372,000USD | 1,341,000USD | -60,417,000USD |
| Unclassified Operating Expenses | — | 8,883,000USD | — | — | — | — | — | — |
| Interest Expense | — | 89,000USD | 0USD | — | — | — | 301,000USD | — |
| Selling And Marketing Expenses | — | — | — | — | — | 12,182,000USD | — | — |
| Income Tax Expense | — | — | — | — | — | 43,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 13,107,000USD | 10,094,000USD | 7,768,000USD | 9,027,000USD | 0USD | 2,914,000USD | 0USD | 0USD |
| Cost Of Revenue | 8,565,000USD | 7,765,000USD | 4,741,000USD | 112,091,000USD | 92,312,000USD | 50,511,000USD | 28,828,000USD | 26,322,000USD |
| Gross Profit | 4,542,000USD | 2,329,000USD | 3,027,000USD | -112,091,000USD | -92,312,000USD | -50,511,000USD | -28,828,000USD | -26,322,000USD |
| Research Development | 44,486,000USD | 40,448,000USD | 86,655,000USD | 81,876,000USD | 68,838,000USD | 36,157,000USD | 18,192,000USD | 17,558,000USD |
| Selling General Administrative | 87,684,000USD | 3,400,000USD | 34,752,000USD | 30,215,000USD | 23,474,000USD | 14,354,000USD | 10,636,000USD | 8,764,000USD |
| Unclassified Operating Expenses | -1,925,000USD | 58,481,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 130,245,000USD | 139,030,000USD | 121,407,000USD | 112,091,000USD | 92,312,000USD | 50,511,000USD | 28,828,000USD | 26,322,000USD |
| Operating Income | -125,703,000USD | -136,701,000USD | -118,380,000USD | -112,091,000USD | -92,312,000USD | -50,511,000USD | -28,828,000USD | -26,322,000USD |
| Interest Income | 4,146,000USD | 22,000USD | 2,763,000USD | 1,873,000USD | 25,000USD | 48,000USD | 210,000USD | 233,000USD |
| Interest Expense | 89,000USD | 1,234,000USD | — | 7,912,000USD | 50,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | 4,057,000USD | -1,212,000USD | 2,763,000USD | 1,873,000USD | 25,000USD | 48,000USD | 210,000USD | 233,000USD |
| Income Before Tax | -124,021,000USD | -130,036,000USD | -116,658,000USD | -110,218,000USD | -92,287,000USD | -50,463,000USD | -28,618,000USD | -26,089,000USD |
| Net Income | -124,021,000USD | -130,036,000USD | -116,658,000USD | -115,004,000USD | -92,212,000USD | -50,388,000USD | -28,382,000USD | -26,089,000USD |
| Net Income From Continuing Ops | -124,021,000USD | -130,036,000USD | -121,016,000USD | -110,218,000USD | -92,287,000USD | -50,463,000USD | -28,618,000USD | -26,089,000USD |
| Ebit | -125,703,000USD | -77,744,000USD | -118,380,000USD | -112,091,000USD | -92,312,000USD | -50,511,000USD | -28,828,000USD | -26,322,000USD |
| Ebitda | -123,778,000USD | -74,323,000USD | -114,089,000USD | -110,838,000USD | -92,262,000USD | -50,484,000USD | -28,802,000USD | -26,268,000USD |
| Depreciation And Amortization | 1,925,000USD | 3,421,000USD | 4,291,000USD | 1,253,000USD | 50,000USD | 27,000USD | 26,000USD | 54,000USD |
| Reconciled Depreciation | 1,925,000USD | 3,421,000USD | 3,866,000USD | 1,253,000USD | 50,000USD | 27,000USD | 26,000USD | 54,000USD |
| Total Other Income Expense Net | 1,682,000USD | 6,665,000USD | 1,722,000USD | 1,873,000USD | 25,000USD | 48,000USD | 210,000USD | 233,000USD |
| Selling And Marketing Expenses | — | 36,701,000USD | — | — | — | — | — | — |
| Income Tax Expense | — | -1,167,000USD | -1USD | 4,786,000USD | -75,000USD | -75,000USD | -236,000USD | 233,000USD |
| Net Income Applicable To Common Shares | — | — | — | -116,877,000USD | -92,287,000USD | -52,174,000USD | -31,092,000USD | -29,355,000USD |
| Non Operating Income Net Other | — | — | — | — | 25,000USD | 48,000USD | 210,000USD | 233,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 257,912,000USD | 277,171,000USD | 252,440,000USD | 187,359,000USD | 192,870,000USD | 162,890,000USD | 94,989,000USD | 70,307,000USD |
| Intangible Assets | 120,000USD | 120,000USD | 120,000USD | 120,000USD | 120,000USD | 120,000USD | 120,000USD | 120,000USD |
| Other Current Assets | 9,233,000USD | 5,470,000USD | 8,806,000USD | 4,346,000USD | 4,894,000USD | 3,914,000USD | 10,366,000USD | 8,335,000USD |
| Total Liab | 30,775,000USD | 32,021,000USD | 21,297,000USD | 19,358,000USD | 12,474,000USD | 23,332,000USD | 20,778,000USD | 28,204,000USD |
| Total Stockholder Equity | 227,137,000USD | 245,150,000USD | 231,143,000USD | 168,001,000USD | 180,396,000USD | 139,558,000USD | 74,211,000USD | 42,103,000USD |
| Other Current Liab | 19,836,000USD | 19,173,000USD | 12,332,000USD | 8,076,000USD | 5,784,000USD | 11,671,000USD | 8,151,000USD | 8,263,000USD |
| Common Stock | 14,000USD | 13,000USD | 10,000USD | 8,000USD | 7,000USD | 4,000USD | 156,000USD | 10,000USD |
| Capital Stock | 14,000USD | 13,000USD | 10,000USD | 8,000USD | 7,000USD | 4,000USD | 156,000USD | 10,000USD |
| Retained Earnings | -894,909,000USD | -854,715,000USD | -807,805,000USD | -775,795,000USD | -747,523,000USD | -730,694,000USD | -708,586,000USD | -694,373,000USD |
| Cash | 185,470,000USD | 207,637,000USD | 190,055,000USD | 125,331,000USD | 131,716,000USD | 98,776,000USD | 28,233,000USD | 4,156,000USD |
| Cash And Short Term Investments | 185,470,000USD | 207,637,000USD | 190,055,000USD | 125,331,000USD | 131,716,000USD | 98,776,000USD | 28,233,000USD | 4,156,000USD |
| Total Current Assets | 207,168,000USD | 228,876,000USD | 208,071,000USD | 143,535,000USD | 149,573,000USD | 119,002,000USD | 50,543,000USD | 25,287,000USD |
| Total Current Liabilities | 29,647,000USD | 30,837,000USD | 21,031,000USD | 19,061,000USD | 12,146,000USD | 18,307,000USD | 15,181,000USD | 22,043,000USD |
| Net Debt | -184,180,000USD | -206,328,000USD | -189,630,000USD | -124,839,000USD | -131,153,000USD | -93,477,000USD | -19,541,000USD | 5,379,000USD |
| Short Term Debt | 162,000USD | 125,000USD | 159,000USD | 195,000USD | 235,000USD | 274,000USD | 3,095,000USD | 3,374,000USD |
| Short Long Term Debt Total | 1,290,000USD | 1,309,000USD | 425,000USD | 492,000USD | 563,000USD | 5,299,000USD | 8,692,000USD | 9,535,000USD |
| Net Receivables | 8,820,000USD | 9,756,000USD | 3,481,000USD | 7,872,000USD | 4,827,000USD | 7,904,000USD | 4,013,000USD | 3,339,000USD |
| Inventory | 3,645,000USD | 6,013,000USD | 5,729,000USD | 5,986,000USD | 8,136,000USD | 8,408,000USD | 7,931,000USD | 9,457,000USD |
| Accounts Payable | 9,649,000USD | 8,114,000USD | 8,540,000USD | 7,783,000USD | 4,193,000USD | 4,546,000USD | 3,935,000USD | 10,406,000USD |
| Property Plant Equipment Net | 46,339,000USD | 46,000,000USD | 42,950,000USD | 42,773,000USD | 42,267,000USD | 42,817,000USD | 43,375,000USD | 43,939,000USD |
| Property Plant Equipment Gross | 52,916,000USD | 52,022,000USD | 48,484,000USD | 47,846,000USD | 46,857,000USD | 46,914,000USD | 46,975,000USD | 47,029,000USD |
| Accumulated Other Comprehensive Income | -283,000USD | -289,000USD | -274,000USD | -270,000USD | -266,000USD | -255,000USD | -250,000USD | -243,000USD |
| Common Stock Shares Outstanding | 13,707,104shares | 8,511,318shares | 8,922,792shares | 7,327,257shares | 5,927,231shares | 2,263,500shares | 5,647shares | 3,714shares |
| Non Current Assets Total | 50,744,000USD | 48,295,000USD | 44,369,000USD | 43,824,000USD | 43,297,000USD | 43,888,000USD | 44,446,000USD | 45,020,000USD |
| Non Current Liabilities Total | 1,128,000USD | 1,184,000USD | 266,000USD | 297,000USD | 328,000USD | 5,025,000USD | 5,597,000USD | 6,161,000USD |
| Non Currrent Assets Other | 4,285,000USD | 46,000,000USD | 1,299,000USD | 31,000USD | 7,000USD | 47,000USD | 51,000USD | 961,000USD |
| Net Working Capital | 177,521,000USD | 198,039,000USD | 187,040,000USD | 124,474,000USD | 137,427,000USD | 100,695,000USD | 35,362,000USD | 3,244,000USD |
| Unclassified Non Current Liabilities | 1,128,000USD | 1,184,000USD | — | — | — | — | — | — |
| Unclassified Equity | 1,122,301,000USD | 1,100,128,000USD | 1,039,202,000USD | 944,050,000USD | 928,171,000USD | 870,499,000USD | 782,735,000USD | 736,699,000USD |
| Current Deferred Revenue | — | 3,425,000USD | — | 3,007,000USD | 1,934,000USD | 1,816,000USD | — | — |
| Unclassified Non Current Assets | — | -43,825,000USD | — | — | — | — | — | — |
| Good Will | — | — | — | — | — | 0USD | 0USD | 0USD |
| Long Term Debt | — | — | — | — | — | 4,667,000USD | 5,172,000USD | 5,668,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 277,171,000USD | 162,890,000USD | 154,457,000USD | 225,690,000USD | 240,900,000USD | 98,183,000USD | 14,558,000USD | 26,319,000USD |
| Intangible Assets | 120,000USD | 120,000USD | 9,743,000USD | 120,000USD | 120,000USD | 120,000USD | 120,000USD | 120,000USD |
| Other Current Assets | 5,470,000USD | 3,914,000USD | 4,083,000USD | 2,505,000USD | 2,663,000USD | 3,294,000USD | 1,688,000USD | 497,000USD |
| Total Liab | 32,021,000USD | 23,332,000USD | 48,932,000USD | 18,508,000USD | 22,183,000USD | 10,535,000USD | 5,141,000USD | 2,655,000USD |
| Total Stockholder Equity | 245,150,000USD | 139,558,000USD | 105,525,000USD | 207,182,000USD | 218,717,000USD | 87,648,000USD | 9,417,000USD | 23,664,000USD |
| Other Current Liab | 22,598,000USD | 11,671,000USD | 9,502,000USD | 6,407,000USD | 5,113,000USD | 2,457,000USD | 1,009,000USD | 1,251,000USD |
| Common Stock | 13,000USD | 4,000USD | 59,000USD | 12,000USD | 496,000USD | 206,000USD | 9,000USD | 3,000USD |
| Capital Stock | 13,000USD | 4,000USD | 59,000USD | 76,000USD | 16,000USD | 206,000USD | 9,000USD | 3,000USD |
| Retained Earnings | -854,715,000USD | -730,694,000USD | -600,658,000USD | -470,038,000USD | -359,820,000USD | -267,533,000USD | -217,070,000USD | -188,452,000USD |
| Cash | 207,637,000USD | 98,776,000USD | 24,948,000USD | 120,229,000USD | 178,660,000USD | 77,068,000USD | 11,249,000USD | 25,034,000USD |
| Cash And Short Term Investments | 207,637,000USD | 98,776,000USD | 24,948,000USD | 120,229,000USD | 178,660,000USD | 77,068,000USD | 11,249,000USD | 25,034,000USD |
| Total Current Assets | 228,876,000USD | 119,002,000USD | 47,768,000USD | 130,777,000USD | 189,049,000USD | 87,989,000USD | 13,948,000USD | 26,056,000USD |
| Total Current Liabilities | 30,837,000USD | 18,307,000USD | 18,884,000USD | 18,180,000USD | 21,716,000USD | 9,819,000USD | 5,135,000USD | 2,655,000USD |
| Net Debt | -206,328,000USD | -93,477,000USD | -15,135,000USD | -119,469,000USD | -177,704,000USD | -75,757,000USD | -10,891,000USD | -25,034,000USD |
| Short Term Debt | 125,000USD | 274,000USD | 2,620,000USD | 432,000USD | 489,000USD | 595,000USD | 352,000USD | — |
| Short Long Term Debt Total | 1,309,000USD | 5,299,000USD | 9,813,000USD | 760,000USD | 956,000USD | 1,311,000USD | 358,000USD | — |
| Net Receivables | 9,756,000USD | 7,904,000USD | 4,590,000USD | 8,043,000USD | 7,726,000USD | 7,627,000USD | 1,011,000USD | 525,000USD |
| Inventory | 6,013,000USD | 8,408,000USD | 14,147,000USD | -8,043,000USD | — | -7,627,000USD | -1,011,000USD | — |
| Accounts Payable | 8,114,000USD | 4,546,000USD | 3,782,000USD | 8,068,000USD | 13,282,000USD | 4,598,000USD | 3,070,000USD | 1,404,000USD |
| Property Plant Equipment Net | 46,000,000USD | 42,817,000USD | 94,852,000USD | 94,529,000USD | 51,472,000USD | 9,829,000USD | 390,000USD | 43,000USD |
| Property Plant Equipment Gross | 52,022,000USD | 46,914,000USD | 100,214,000USD | 96,182,000USD | 51,872,000USD | 9,829,000USD | 390,000USD | 43,000USD |
| Accumulated Other Comprehensive Income | -289,000USD | -255,000USD | -232,000USD | -167,000USD | -92,000USD | -62,000USD | -46,000USD | -41,000USD |
| Common Stock Shares Outstanding | 8,511,318shares | 736,339shares | 7,925shares | 292shares | 563shares | 148shares | 3shares | 0shares |
| Non Current Assets Total | 48,295,000USD | 43,888,000USD | 106,689,000USD | 94,913,000USD | 51,851,000USD | 10,194,000USD | 610,000USD | 263,000USD |
| Non Current Liabilities Total | 1,184,000USD | 5,025,000USD | 30,048,000USD | 328,000USD | 467,000USD | 716,000USD | 6,000USD | 0USD |
| Non Currrent Assets Other | 2,175,000USD | 47,000USD | 1,129,000USD | 264,000USD | 259,000USD | 245,000USD | 100,000USD | 100,000USD |
| Net Working Capital | 198,039,000USD | 100,695,000USD | 28,884,000USD | 112,597,000USD | 167,333,000USD | 78,170,000USD | 8,813,000USD | 23,401,000USD |
| Unclassified Non Current Liabilities | 1,184,000USD | — | 23,487,000USD | — | — | — | -5,141,000USD | — |
| Unclassified Equity | 1,100,128,000USD | 870,499,000USD | 706,297,000USD | 677,299,000USD | 578,117,000USD | 354,831,000USD | 226,515,000USD | 212,151,000USD |
| Good Will | — | 0USD | 965,000USD | 0USD | — | — | — | — |
| Current Deferred Revenue | — | 1,816,000USD | 2,980,000USD | 3,273,000USD | 2,832,000USD | 2,169,000USD | 704,000USD | 475,000USD |
| Long Term Debt | — | 4,667,000USD | 6,561,000USD | — | — | — | — | — |
| Other Assets | — | — | — | 384,000USD | — | 1,503,000USD | 100,000USD | 100,000USD |
| Net Tangible Assets | — | — | — | 207,182,000USD | — | 87,528,000USD | 9,297,000USD | 23,544,000USD |
| Non Current Liabilities Other | — | — | — | — | — | 716,000USD | 6,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | -1,503,000USD | — | — |
| Other Liab | — | — | — | — | — | — | 5,141,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -40,194,000USD | -46,910,000USD | -32,009,999USD | -28,272,000USD | -16,829,000USD | -22,108,000USD | -14,213,000USD | -78,776,000USD |
| Depreciation | 555,000USD | 488,000USD | 461,000USD | 483,000USD | 493,000USD | 496,000USD | 510,000USD | 1,205,000USD |
| Stock Based Compensation | 1,970,000USD | 1,807,000USD | 1,800,000USD | 1,423,000USD | 882,000USD | 894,000USD | 1,038,000USD | 1,154,000USD |
| Other Non Cash Items | 1,970,000USD | -830,948USD | 1,371,999USD | 4,117,000USD | 2,157,000USD | -328,000USD | 489,000USD | 61,679,000USD |
| Change To Account Receivables | -2,548,000USD | -2,900,114USD | -1,193,000USD | 992,000USD | 371,000USD | 1,299,000USD | -1,643,000USD | -3,339,000USD |
| Change To Inventory | 2,369,000USD | 362,078USD | 1,220,000USD | -130,000USD | 272,000USD | 50,000USD | 1,247,000USD | 1,156,000USD |
| Change In Working Capital | -4,649,000USD | 5,795,948USD | -405,000USD | 7,416,000USD | -3,282,000USD | 6,416,000USD | -6,625,000USD | 4,819,000USD |
| Total Cash From Operating Activities | -42,318,000USD | -39,650,000USD | -28,782,000USD | -14,833,000USD | -16,579,000USD | -14,630,000USD | -18,801,000USD | -9,919,000USD |
| Capital Expenditures | -1,692,000USD | -1,874,000USD | -962,000USD | -2,539,000USD | -6,000USD | -3,000USD | -9,000USD | -1,771USD |
| Free Cash Flow | -44,010,000USD | -41,524,000USD | -29,744,000USD | -17,372,000USD | -16,585,000USD | -14,633,000USD | -18,810,000USD | -9,919,000USD |
| Total Cashflows From Investing Activities | -1,692,000USD | -1,021,000USD | -962,000USD | -2,539,000USD | -6,000USD | -3,000USD | -9,000USD | 1,771USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | -9,650,000USD | -705,000USD | -705,000USD | — |
| Total Cash From Financing Activities | 20,205,000USD | 59,143,000USD | 94,861,000USD | 10,993,000USD | 49,533,000USD | 85,154,000USD | 42,905,000USD | 7,025,000USD |
| Sale Purchase Of Stock | 0USD | -8,071,834USD | 260,834USD | -2,902,000USD | -3,047,000USD | 0USD | 0USD | 0USD |
| Issuance Of Capital Stock | 20,126,000USD | 66,954,000USD | 94,861,000USD | 13,895,000USD | 62,230,000USD | 85,859,000USD | 43,606,000USD | 10,730,000USD |
| Change In Cash | -22,167,000USD | 18,458,000USD | 65,113,000USD | -6,383,000USD | 32,939,000USD | 70,544,000USD | 24,078,000USD | -2,893,000USD |
| Begin Period Cash Flow | 207,637,000USD | 191,349,000USD | 126,236,000USD | 132,619,000USD | 99,680,000USD | 29,136,000USD | 5,058,000USD | 7,951,000USD |
| End Period Cash Flow | 185,470,000USD | 209,807,000USD | 191,349,000USD | 126,236,000USD | 132,619,000USD | 99,680,000USD | 29,136,000USD | 5,058,000USD |
| Other Cashflows From Financing Activities | 20,205,000USD | -469,840USD | 94,861,000USD | -2,653,771USD | -9,650,000USD | 338,940USD | 4,000USD | -3,000,000USD |
| Unclassified Operating Cash Flow | -1,970,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | 853,000USD | — | -2,012,000USD | — | — | 1,771USD | — |
| Unclassified Financing Cash Flow | — | 67,684,674USD | — | 16,548,771USD | 71,880,000USD | 85,520,060USD | 43,606,000USD | 10,025,000USD |
| Investments | — | — | -962,000USD | -2,539,000USD | -6,000USD | -3,000USD | -9,000USD | 0USD |
| Unclassified Investing Cash Flow | — | — | — | 4,551,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -124,021,000USD | -130,036,000USD | -116,658,000USD | -110,218,000USD | -92,287,000USD | -50,463,000USD | -28,618,000USD | -26,089,000USD |
| Depreciation | 1,925,000USD | 3,421,000USD | 4,291,000USD | 1,253,000USD | 50,000USD | 27,000USD | 26,000USD | 54,000USD |
| Stock Based Compensation | 6,017,000USD | 4,778,000USD | 9,275,000USD | 10,914,000USD | 7,899,000USD | 2,876,000USD | 1,457,000USD | 1,627,000USD |
| Other Non Cash Items | 7,690,000USD | 55,137,000USD | 1,124,000USD | 14,465,000USD | 3,000,000USD | 1,360,000USD | 15,040,000USD | 1,629,000USD |
| Change To Account Receivables | -2,619,000USD | -3,683,000USD | 0USD | — | — | — | — | — |
| Change To Inventory | 1,726,000USD | 3,741,000USD | 61,000USD | 0USD | — | — | — | — |
| Change In Working Capital | 8,545,000USD | 5,775,000USD | -35,000USD | -2,000USD | 5,781,000USD | -2,366,000USD | 452,000USD | 437,000USD |
| Total Cash From Operating Activities | -99,844,000USD | -60,925,000USD | -102,003,000USD | -98,053,000USD | -75,557,000USD | -48,566,000USD | -26,683,000USD | -23,971,000USD |
| Capital Expenditures | -3,369,000USD | -120,000USD | -7,895,000USD | -48,147,000USD | -35,307,000USD | -8,564,000USD | -17,000USD | -6,000USD |
| Free Cash Flow | -103,213,000USD | -61,045,000USD | -109,898,000USD | -146,200,000USD | -110,864,000USD | -57,130,000USD | -26,700,000USD | -23,977,000USD |
| Total Cashflows From Investing Activities | -4,528,000USD | -120,000USD | -29,070,000USD | -48,147,000USD | -35,307,000USD | -8,564,000USD | -17,000USD | -6,000USD |
| Net Borrowings | -9,650,000USD | -2,350,000USD | 8,942,000USD | 0USD | — | — | — | — |
| Total Cash From Financing Activities | 214,530,000USD | 134,872,000USD | 36,517,000USD | 87,844,000USD | 212,487,000USD | 123,105,000USD | 12,919,000USD | 23,539,000USD |
| Sale Purchase Of Stock | -13,760,000USD | 0USD | -13,965,000USD | -47,250,000USD | 3,000,000USD | 1,360,000USD | 12,919,000USD | 23,539,000USD |
| Issuance Of Capital Stock | 237,940,000USD | 140,195,000USD | 32,718,000USD | 135,054,000USD | 212,389,000USD | 113,207,000USD | 12,849,000USD | 23,539,000USD |
| Change In Cash | 110,127,000USD | 73,831,000USD | -94,621,000USD | -58,430,000USD | 101,592,000USD | 65,959,000USD | -13,785,000USD | -451,000USD |
| Begin Period Cash Flow | 99,680,000USD | 25,849,000USD | 120,470,000USD | 178,900,000USD | 77,308,000USD | 11,349,000USD | 25,134,000USD | 25,585,000USD |
| End Period Cash Flow | 209,807,000USD | 99,680,000USD | 25,849,000USD | 120,470,000USD | 178,900,000USD | 77,308,000USD | 11,349,000USD | 25,134,000USD |
| Other Cashflows From Investing Activities | -1,159,000USD | — | 999,000USD | — | — | — | -17,000USD | -6,000USD |
| Other Cashflows From Financing Activities | 214,530,000USD | -2,973,000USD | 22,601,000USD | 47,290,000USD | 98,000USD | 14,500,000USD | 9,524,000USD | 14,091,000USD |
| Unclassified Financing Cash Flow | 23,410,000USD | 140,195,000USD | 18,939,000USD | 94,463,000USD | 209,389,000USD | 107,696,000USD | -7,050,000USD | -10,825,000USD |
| Investments | — | -120,000USD | -33,310,000USD | -48,147,000USD | -35,307,000USD | -8,564,000USD | -17,000USD | -6,000USD |
| Unclassified Investing Cash Flow | — | — | 11,136,000USD | 48,147,000USD | 35,307,000USD | 8,564,000USD | — | — |
| Change To Liabilities | — | — | — | -1,045,000USD | 3,526,000USD | 1,528,000USD | 2,125,000USD | 516,000USD |
| Dividends Paid | — | — | — | -6,659,000USD | — | -451,000USD | -2,474,000USD | -3,266,000USD |
| Unclassified Operating Cash Flow | — | — | — | -14,465,000USD | — | — | -15,040,000USD | -1,629,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 101,623,000USD | 65,975,000USD | -13,781,000USD | -451,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -13,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Tonmya | 3,731,000 | USD | 0001999371-26-010486 |
| Q1 2026Quarterly · 2026-03-31 | Product | Tosymra | 217,000 | USD | 0001999371-26-010486 |
| Q1 2026Quarterly · 2026-03-31 | Product | Zembrace Symtouch | 2,930,000 | USD | 0001999371-26-010486 |
| FY 2025Yearly · 2025-12-31 | Product | Tonmya | 1,421,000 | USD | 0001999371-26-005730 |
| FY 2025Yearly · 2025-12-31 | Product | Tosymra | 2,372,000 | USD | 0001999371-26-005730 |
| FY 2025Yearly · 2025-12-31 | Product | Zembrace Symtouch | 9,314,000 | USD | 0001999371-26-005730 |
| Q3 2025Quarterly · 2025-09-30 | Product | Tosymra | 708,000 | USD | 0001999371-25-017370 |
| Q3 2025Quarterly · 2025-09-30 | Product | Zembrace Symtouch | 2,582,000 | USD | 0001999371-25-017370 |
| Q2 2025Quarterly · 2025-06-30 | Product | Tosymra | 428,000 | USD | 0001999371-25-011050 |
| Q2 2025Quarterly · 2025-06-30 | Product | Zembrace Symtouch | 1,570,000 | USD | 0001999371-25-011050 |
| Q1 2025Quarterly · 2025-03-31 | Product | Tosymra | 403,000 | USD | 0001999371-26-010486 |
| Q1 2025Quarterly · 2025-03-31 | Product | Zembrace Symtouch | 2,026,000 | USD | 0001999371-26-010486 |
| Q4 2024Quarterly · 2024-12-31 | Product | Tosymra | 95,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Zembrace Symtouch | 2,487,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Tosymra | 1,548,000 | USD | 0001999371-26-005730 |
| FY 2024Yearly · 2024-12-31 | Product | Zembrace Symtouch | 8,546,000 | USD | 0001999371-26-005730 |
| Q3 2024Quarterly · 2024-09-30 | Product | Tosymra | 337,000 | USD | 0001999371-25-017370 |
| Q3 2024Quarterly · 2024-09-30 | Product | Zembrace Symtouch | 2,485,000 | USD | 0001999371-25-017370 |
| Q2 2024Quarterly · 2024-06-30 | Product | Tosymra | 481,000 | USD | 0001999371-25-011050 |
| Q2 2024Quarterly · 2024-06-30 | Product | Zembrace Symtouch | 1,727,000 | USD | 0001999371-25-011050 |
| Q1 2024Quarterly · 2024-03-31 | Product | Tosymra | 635,000 | USD | 0001999371-25-005875 |
| Q1 2024Quarterly · 2024-03-31 | Product | Zembrace Symtouch | 1,847,000 | USD | 0001999371-25-005875 |
| FY 2023Yearly · 2023-12-31 | Product | Tosymra | 1,464,000 | USD | 0001999371-25-002786 |
| FY 2023Yearly · 2023-12-31 | Product | Zembrace Symtouch | 6,304,000 | USD | 0001999371-25-002786 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.